Cero Therapeutics Hldgs Inc.

13F holders, Q4 2024 (December 31)
20holders +2
10new positions
8sold out
1famous investor
$0.06avg. 13F price*

At the end of Q4 2024, 20 institutions reported holding Cero Therapeutics Hldgs Inc. in their 13F filings, up 2 from Q3 2024. 10 opened new positions and 8 sold out. The largest holders were ARCH Venture Management, LLC ($564K), Avantax Planning Partners, Inc. ($155K) and Cubist Systematic Strategies, LLC ($20K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).

Company
Cero Therapeutics Hldgs Inc.
CUSIP
71902K105
Latest filing quarter
Q4 2024

History

Number of 13F holders

05101520 Q1 2024: 9Q1 2024Q2 2024: 15Q2 2024Q3 2024: 18Q3 2024Q4 2024: 20Q4 2024

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions10$65K
Exits8$38K

All 13F filers, Q3 2024 → Q4 2024: 10,310,187 shares bought and 413,979 shares sold, net +9,896,208 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

ARCH Venture Management, LLC 0.24% Add +550.4% 9,393,561 $564K
Avantax Planning Partners, Inc. 0.01% Add +89.9% 2,585,151 $155K
Cubist Systematic Strategies, LLC 0.00% New 333,442 $20K
Vanguard Personalized Indexing Management, LLC 0.00% New 234,657 $14K
Cantor Fitzgerald, L. P. 0.00% New 155,000 $10K
Goldman Sachs Group Inc. 0.00% New 162,474 $10K
Selkirk Management LLC 0.00% No change 121,040 $7K
Tower Research Capital LLC (TRC) 0.00% Add +1383.8% 73,670 $4K
Millennium Management 0.00% New 63,054 $4K
Jane Street Group, LLC 0.00% Add +0.8% 57,459 $3K
SG Americas Securities, LLC 0.00% New 25,752 $2K
Revolve Wealth Partners, LLC 0.00% New 32,799 $2K
HBK Sorce Advisory LLC 0.00% New 26,249 $2K
FNY Investment Advisers, LLC 0.00% No change 26,250 $2K
Guidance Point Advisors, LLC 0.00% New 18,717 $1K
Marex Group Ltd 0.00% New 15,000 $900
Birchview Capital, LP 0.00% No change 12,972 $778
Bank of America Corp. 0.00% Add +195.3% 685 $41
Osaic Holdings, Inc. 0.00% No change 400 $24
JPMorgan Chase & Co. 0.00% Add +6900.0% 140 $8

"% of holder's portfolio" is CERO THERAPEUTICS HLDGS INC's weight in each manager's 13F, not the share of Cero Therapeutics Hldgs Inc. the manager owns.